NPIP inhibitors are a class of chemical compounds that function by targeting and modulating the activity of specific proteins involved in cellular pathways. "NPIP" typically refers to a protein or molecular target that these inhibitors are designed to interact with, although the exact nature of "NPIP" can vary depending on the context of its application. Structurally, NPIP inhibitors can be highly diverse, ranging from small organic molecules to more complex entities with multiple functional groups that allow specific binding and inhibition of their target protein. These inhibitors often feature key structural motifs that facilitate high-affinity binding to their target through interactions like hydrogen bonding, hydrophobic contacts, or π-π stacking. The chemical properties of NPIP inhibitors, such as lipophilicity, polarity, and molecular weight, are finely tuned to achieve optimal binding and activity.
The mechanism of action of NPIP inhibitors generally involves the disruption or modulation of protein-protein interactions or catalytic activities associated with the "NPIP" protein. By binding to the active site or an allosteric site on their target, NPIP inhibitors can alter the function of the protein, thereby affecting the downstream signaling pathways or biochemical processes in which the protein is involved. Because these inhibitors have a targeted approach to modulating specific proteins, their design often requires detailed knowledge of the protein's structure, binding pockets, and conformational dynamics. This allows for the rational design of inhibitors that are not only effective but also selective, minimizing off-target effects. The study of NPIP inhibitors encompasses various techniques, including structure-activity relationship (SAR) analyses, computational modeling, and in vitro biochemical assays to understand their binding affinities and inhibitory potency. Through these approaches, researchers can explore the potential of NPIP inhibitors to affect cellular processes by modulating the function of their specific protein targets.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A non-selective kinase inhibitor that can impede protein function by altering phosphorylation states. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can disrupt downstream signaling pathways, including those potentially involving NPIP. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A MEK inhibitor which can prevent the activation of MAPK/ERK pathway, potentially affecting NPIP-related processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor which can alter cell growth and proliferation signals, potentially affecting proteins like NPIP. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, which can block signaling pathways in which the NPIP protein may participate. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can disrupt inflammatory and stress response pathways involving NPIP. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which can block the MAPK/ERK pathway and potentially affect NPIP function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can interfere with stress response and apoptosis pathways, potentially involving NPIP. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can change gene expression profiles and potentially impact NPIP activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can lead to a buildup of misfolded proteins and disrupt cellular homeostasis, affecting NPIP indirectly. | ||||||